The power of relationships: Implications for safer and unsafe practices among injection drug users

References

• Balian R. Myth, truth and HIV, a user's perspective on the seroconversion rates, in Vancouver, Montreal and Ottawa. International Journal of Drug Policy 1998; 9: 359–364
   Google Scholar
• Ball AL. HIV, injecting drug use and harm reduction: A public health response. Addiction 2007; 102: 684–690
   PubMed Web of Science ®Google Scholar
• Branigan P, Wellings K. Acceptance of the harm minimization message in London clubs and underground system. Drugs: Education, Prevention and Policy 1999; 6(3)389–398
   Web of Science ®Google Scholar
• Burris S. Stigma and the law. The Lancet 2006; 367: 529–531
   PubMed Web of Science ®Google Scholar
• CCSA National Policy Working Group. Harm reduction: Concepts and practice. Canadian Centre on Substance Abuse, Ottawa, ON 1996
   Google Scholar
• Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors’ ability to practice harm reduction: A qualitative study. Social Science and Medicine 2005; 61(3)673–684
   PubMed Web of Science ®Google Scholar
• Costenbader EC, Astone NM, Latkin CA. The dynamics of injection drug users’ personal networks and HIV risk behaviours. Addiction 2006; 101: 1003–1013
   PubMed Web of Science ®Google Scholar
• Côté F, Godin G, Mercure SA, Nöel L, Alary M. Preventing HIV transmission among marginalized injection drug users: New insights from a Québec City based research. International Journal of Drug Policy 2006; 17: 411–417
   Web of Science ®Google Scholar
• Day C, Conroy E, Lowe J, Page J, Dolan K. Patterns of drug use and associated harms among rural injecting drug users: Comparisons with metropolitan injecting drug users. Australian Journal of Rural Health 2006; 14: 120–125
   PubMedGoogle Scholar
• Eaves CS. Heroin use among female adolescents: The role of partner influence in path of initiation and route of administration. The American Journal of Drug and Alcohol Abuse 2004; 30(1)21–38
   PubMed Web of Science ®Google Scholar
• Emmanuelli J, Desenclos JC. Harm reduction interventions, behaviours and associated health outcomes in France, 1996–2003. Addiction 2005; 100: 1690–1700
   PubMed Web of Science ®Google Scholar
• Erickson PG, Riley DM, Cheung YW. Harm Reduction: A New Direction for Drug Policies and Programs, PA O’Hare. University of Toronto Press Incorporated, Toronto, ON 1997
   Google Scholar
• Ezard N. Public health, human rights and the harm reduction paradigm: From risk reduction to vulnerability reduction. International Journal of Drug Policy 2001; 12: 207–209
   Google Scholar
• Fischer B, Kalousek K, Rehm J, Powis J, Krajden M, Reimer J. Hepatitis C, illicit drug use and public health: Does Canada really have a viable plan?. Canadian Journal of Public Health 2006; 97(6)485–488
   PubMed Web of Science ®Google Scholar
• Fraser S. ‘It's your life!’: Injecting drug users, individual responsibility and hepatitis C prevention. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine 2004; 8(2)199–221
   Web of Science ®Google Scholar
• Gogineni A, Stein MD, Friedmann PD. Social relationships and intravenous drug use among methadone maintenance patients. Drug and Alcohol Dependence 2001; 64(1)47–53
   PubMed Web of Science ®Google Scholar
• Hwang S. Science and ideology. Open Medicine 2007; 1(2)E99–101
   PubMedGoogle Scholar
• Jackson L, Bailey D, Fraser J, Johnson K, Currie A, Babineau D. Safer and unsafe injection drug use and sex practices among injection drug users in Halifax, Nova Scotia: An explanatory look at community and interpersonal influences. Canadian Journal of Public Health 2002; 93(3)219–222
   PubMed Web of Science ®Google Scholar
• Keane H. Critiques of harm reduction, morality and the promise of human rights. International Journal of Drug Policy 2003; 14: 227–232
   Google Scholar
• Levy JA, Anderson T. The drug career of the older injector. Addiction Research and Theory 2005; 13(3)245–258
   Web of Science ®Google Scholar
• Lovell AM. Risking risk: The influence of types of capital and social networks on the injection practices of drug users. Social Science & Medicine 2002; 55(5)803–821
   PubMed Web of Science ®Google Scholar
• Mangham C. Harm reduction and illegal drugs: The real debate. Canadian Journal of Public Health 2001; 92(3)204–205
   PubMed Web of Science ®Google Scholar
• Mateu-Gelabert P, Treloar C, Agulló Calatayud V, Sandoval M, Valderrama Zurián JC, Maher L, et al. How can hepatitis C be prevented in the long term?. International Journal of Drug Policy 2007; 18: 338–340
   PubMed Web of Science ®Google Scholar
• Miller PG. A critical review of the harm minimization ideology in Australia. Critical Public Health 2001; 11(2)167–178
   Google Scholar
• Moore D, Fraser S. Putting at risk what we know: Reflecting on the drug-using subject in harm reduction and its political implications. Social Science & Medicine 2006; 62: 3035–3047
   PubMed Web of Science ®Google Scholar
• Neaigus A, Friedman S, Curtis R, DesJarlais D, Gurst R, Jose B, et al. The relevance of drug injectors’ social and risk networks for understanding and preventing HIV infection. Social Science & Medicine 1993; 38(1)67–78
   Web of Science ®Google Scholar
• Nelles B. Comment on ‘What are drug users looking for when they contact drug services: Abstinence or harm reduction?’ by Neil McKeganey, Zoe Morris, Joanne Neal, & Michele Robertson. Drugs: Education, Prevention and Policy 2005; 12(4)255–256
   Web of Science ®Google Scholar
• Public Health Agency of Canada (PHAC). Environmental scan of injection drug user, related infectious diseases, high-risk behaviours, and relevant programming in Atlantic Canada. Public Health Agency of Canada, Halifax, NS 2006
   Google Scholar
• Rhodes T. The ‘risk environment’: A framework for understanding and reducing drug-related harm. International Journal of Drug Policy 2002; 13: 85–94
   Google Scholar
• Rhodes T, Kimber J, Small W, Fitzgerald J, Kerr T, Hickman M, et al. For debate: Public injection and the need for ‘safer environment interventions’ in the reduction of drug-related harm. Addiction 2006; 101(10)1384–1393
   PubMed Web of Science ®Google Scholar
• Roe G. Harm reduction as paradigm: Is better than bad good enough? The origins of harm reduction. Critical Public Health 2005; 15(3)243–250
   Google Scholar
• Small W, Kain S, LaLiberte N, Schechter M, O'Shaughnessy MV, Spittal PM. Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Substance Use & Misuse 2005; 40: 831–843
   PubMed Web of Science ®Google Scholar
• Smythe BP, Barry J, Keenan E. Syringe borrowing persists in Dublin despite harm reduction interventions. Addiction 2001; 96: 717–727
   PubMed Web of Science ®Google Scholar
• Statistics Canada. Population and dwelling count highlight tables, 2006 census 2007, Available from: http://www12.statcan.ca/english/census06/data/popdwell/Tables.cfm
   Google Scholar
• Strauss A, Corbin J. Basics of qualitative research: Techniques and procedures for developing grounded theory. Sage, Thousand Oaks, CA 1998
   Google Scholar
• Watters JK, Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Problems 1989; 36(4)416–430
   Web of Science ®Google Scholar
• Weeks MR, Clair S, Borgatti SP, Radda K, Schensul JJ. Social networks of drug users in high-risk sites: Finding the connections. AIDS and Behavior 2002; 6(2)193–206
   Google Scholar
• Wood E, Tyndall M, Montaner J, Kerr T. Summary of findings from the evaluation of a pilot medically supervised safer injection facility. Canadian Medical Association Journal 2006; 175(11)1399–1404
   PubMed Web of Science ®Google Scholar